NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
about
Plasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsExternal quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillanceImpact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.Recent advances in recombinant protein-based malaria vaccines.Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Progress and prospects for blood-stage malaria vaccinesDiagnosis and treatment based on quantitative PCR after controlled human malaria infection.Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity.Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum.Odours of Plasmodium falciparum-infected participants influence mosquito-host interactions.Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.Controlled human malaria infection.Controlled Human Malaria Infection: Applications, Advances and Challenges.Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers.A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection.Comparative Heterochromatin Profiling Reveals Conserved and Unique Epigenome Signatures Linked to Adaptation and Development of Malaria Parasites.The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites.Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study
P2860
Q28066456-8F653045-97DE-4043-82E3-4726AAE57971Q28538917-24A0536E-DF28-45B2-8CF2-0419C0A62929Q35439859-4B78ADDF-D085-437A-B6A7-A98E7558A88BQ35560599-98A5C7B2-C9E4-4BEB-927F-46F58A6F64E9Q36247418-2CD950D2-E4C4-4532-AC87-2BBB69A9076AQ36267184-E28341C7-3033-40E9-BFC5-41EFB0708DF0Q36394182-88074782-8F71-42F0-B4E2-6BA7094DC33CQ36644534-C30F9CA8-E53C-4558-B62F-115C7A6E17CBQ36871970-920FFBC7-C427-408E-B203-DDCBAE29EF18Q37025030-B7A50A90-76EE-4604-A96E-FE55326D3B9FQ37154138-579BDCF5-0937-4D4C-A173-B6C1781BA682Q37361903-8C03E182-7764-4AF8-BADF-C7CBED46DAEEQ37400894-DBB52FC9-3E7C-4EA4-8D94-B813146FC97BQ37546481-BE1660FD-79DC-411B-AB46-7B78FE50E84AQ38714971-0351D9E8-820B-4922-9A63-0AFE04382A21Q38728601-EA56CA08-7BD9-4ED9-B401-CBC76E45AA02Q38964786-93F6D2D4-1031-4E0C-A29C-5F0B96F74952Q40042826-76356C5A-5671-4D45-8F99-C2E917FBC975Q40205689-43A5BED5-B292-4823-B16F-BF67DDB6BDB3Q44168331-4D8B21BB-2545-4A4B-9F71-01ABC5D35F6EQ44169768-D50A9658-7518-49DE-A370-DE53B6C0747EQ47547431-CF112428-4A9C-46D0-BEDC-B91319BACB92Q51417360-F8609A68-8B47-4068-9524-82C47E6CFFE0Q52675072-8EB3EA14-E959-48FE-8200-3ED217131AEEQ55353878-0F02067C-670A-4390-961D-D03D1E38A40FQ58714876-D391B386-045D-4881-8FF6-D98395D34D2C
P2860
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@ast
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@en
type
label
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@ast
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@en
prefLabel
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@ast
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@en
P2093
P2860
P50
P356
P1476
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
@en
P2093
Adrian J F Luty
Anne C Teirlinck
B Kim Lee Sim
Cornelus C Hermsen
Karina Teelen
Krystelle Nganou-Makamdop
Marianne A A Erkens
Martijn W Vos
Meta Roestenberg
Moniek J L Heinrichs
P2860
P304
P356
10.1093/INFDIS/JIS725
P407
P50
P577
2012-11-27T00:00:00Z